Test Directory

Test Code
C5078
Test Name
Marfan Syndrome, Syndrome, Loeys-Dietz Familial Thoracic Aortic Aneurysms & Dissections
CPT Codes
81410
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of Marfan syndrome, Loeys-Dietz syndrome, and thoracic aortic aneurysm disorder. This panel is designed to detect mutations in genes causing aneurysms of the aorta and its major branches. Recommended for individuals with a personal and/or family history of Marfan syndrome, Loeys-Dietz syndrome, or thoracic aortic aneurysm disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens


Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)


Prenatal Specimens

Either specimen type below is acceptable.


Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.


NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
  • MFS
  • LDS
  • FTAAD
Description

The Marfan Syndrome, Loeys-Dietz Syndrome, Familial Thoracic Aortic Aneurysms & Dissections, and Related Disorders NGS Panel is designed to be a cost effective method for detecting mutations in genes causing aneurysms of the aorta and its major branches. Mutations in the genes on this panel cause numerous disorders with variable but often overlapping phenotypes that should be considered in the differential diagnosis of patients presenting with aneurysms. In many instances, different mutations within any gene have been reported to result in variable phenotypes. The genes constituting this panel have been carefully selected so that they are truly representative of those associated with aneurysms of the major vessels.

 

Gene

Disorder

MIM

Inheritance

ACTA2

Aortic aneurysm, familial thoracic 6 (AAT6)

Multisystemic smooth muscle dysfunction syndrome

611788,

613834

AD

BGN

Meester-Loeys syndrome (MRLS)

300989

XL

CBS

Homocystinuria due to cystathionine beta-synthase deficiency

236200

AR

COL3A1

Ehlers-Danlos syndrome, type IV (EDSVASC)

130050

AD

COL5A1

Ehlers-Danlos syndrome, classic type, 1 (EDSCL1)

130000

AD

COL5A2

Ehlers-Danlos syndrome, classic type, 2 (EDSCL2)

130010

AD

FBN1

Marfan syndrome (MFS)

154700

AD

FBN2

Arthrogryposis, distal, type 9 (DA9)

121050

AD

FLNA

Cardiac valvular dysplasia, X-linked (CVD1)

Periventricular nodular heterotopia 1 (PVNH1)

314400

300049

XLR

XLD

FOXE3

Aortic aneurysm, familial thoracic 11, susceptibility to (AAT11)

617349

AD

LOX

Aortic aneurysm, familial thoracic 10 (AAT10)

617168

AD

LTBP3

Aortic aneurysm and dissection, LTBP3 related

-

AD/AR

MAT2A

MAT2A related aortic aneurysm, familial thoracic

-

AD

MFAP5

Aortic aneurysm, familial thoracic 9 (AAT9)

616166

AD

MED12

Lujan-Fryns syndrome

309520

XLR

MYH11

Aortic aneurysm, familial thoracic 4 (AAT4)

132900

AD

MYLK

Aortic aneurysm, familial thoracic 7 (AAT7)

613780

AD

NOTCH1

Aortic valve disease 1 (AOVD1)

109730

AD

PRKG1

Aortic aneurysm, familial thoracic 8 (AAT8)

615436

AD

SKI

Shprintzen-Goldberg craniosynostosis syndrome (SGS)

182212

AD

SLC2A10

Arterial tortuosity syndrome (ATS)

208050

AR

SMAD2

Arterial aneurysm and dissection, SMAD2 related

617349

AD

SMAD3

Loeys-Dietz syndrome 3 (LDS3)

613795

AD

SMAD4

Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPHT)

175050

AD

TGFB2

Loeys-Dietz syndrome 4 (LDS4)

614816

AD

TGFB3

Loeys-Dietz syndrome 5 (LDS5)

615582

AD

TGFBR1

Loeys-Dietz syndrome 1 (LDS1)

609192

AD

TGFBR2

Loeys-Dietz syndrome 2 (LDS2)

610168

AD

Testing Schedule
Monday-Friday
Genes
FBN1, LTBP3, SMAD2, TGFB3, SMAD4, MAT2A, COL5A2, MED12, SKI, TGFB2, COL3A1, PRKG1, ACTA2, FLNA, LOX, BGN, MYH11, FBN2, TGFBR1, SMAD3, MFAP5, NOTCH1, SLC2A10, MYLK, COL5A1, CBS, TGFBR2, FOXE3
MIM
182212, 175050, 614816, 611788, 610380, 608967, 609192, 208050, 613780, 615436, 132900, 613795, 121050, 154700, 109730, 130050, 309520, 610168, 236200